ATE307621T1 - Mit zellen beschichtete träger - Google Patents
Mit zellen beschichtete trägerInfo
- Publication number
- ATE307621T1 ATE307621T1 AT98915561T AT98915561T ATE307621T1 AT E307621 T1 ATE307621 T1 AT E307621T1 AT 98915561 T AT98915561 T AT 98915561T AT 98915561 T AT98915561 T AT 98915561T AT E307621 T1 ATE307621 T1 AT E307621T1
- Authority
- AT
- Austria
- Prior art keywords
- cell
- wounds
- enclosure
- cells
- coated supports
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Fuel Cell (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/840,804 US5972332A (en) | 1997-04-16 | 1997-04-16 | Wound treatment with keratinocytes on a solid support enclosed in a porous material |
PCT/US1998/007480 WO1998046082A1 (en) | 1997-04-16 | 1998-04-15 | Cell-coated supports |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE307621T1 true ATE307621T1 (de) | 2005-11-15 |
Family
ID=25283281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98915561T ATE307621T1 (de) | 1997-04-16 | 1998-04-15 | Mit zellen beschichtete träger |
Country Status (7)
Country | Link |
---|---|
US (6) | US5972332A (de) |
EP (2) | EP0975226B1 (de) |
AT (1) | ATE307621T1 (de) |
AU (1) | AU6971198A (de) |
DE (2) | DE69832054T2 (de) |
ES (2) | ES2292034T3 (de) |
WO (1) | WO1998046082A1 (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US20030105007A1 (en) * | 1995-06-07 | 2003-06-05 | Andre Beaulieu | PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds |
US20020037566A1 (en) * | 1997-04-16 | 2002-03-28 | Rees Riley S. | Cell-coated supports |
US5972332A (en) * | 1997-04-16 | 1999-10-26 | The Regents Of The University Of Michigan | Wound treatment with keratinocytes on a solid support enclosed in a porous material |
US7056503B2 (en) * | 1999-08-19 | 2006-06-06 | Regents Of The University Of Michigan | Enclosures housing cell-coated supports for treating tumors |
US7700660B2 (en) * | 2000-05-31 | 2010-04-20 | Encelle, Inc. | Method of treating chronic ulcers |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
EP1345602B1 (de) | 2000-11-30 | 2010-07-21 | Novodermix International Limited | Heilung von wunden |
US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
US8083768B2 (en) * | 2000-12-14 | 2011-12-27 | Ensure Medical, Inc. | Vascular plug having composite construction |
US6730509B2 (en) * | 2001-01-17 | 2004-05-04 | Bioverse, Inc. | Controlled release dispenser |
US20080086792A1 (en) | 2006-10-13 | 2008-04-17 | Thomas Charles Kuracina | Method and apparatus for diverting sweat, liquid, moisture or the like from an eye |
NZ535136A (en) | 2002-02-21 | 2006-03-31 | Encelle Inc | Immobilized bioactive hydrogel matrices as surface coatings |
ATE521697T1 (de) * | 2002-03-29 | 2011-09-15 | Singapore Eye Res Inst | Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
SG172478A1 (en) * | 2002-10-25 | 2011-07-28 | Revance Therapeutics Inc | Modulation of zinc levels to improve tissue properties |
EP1845107B1 (de) | 2003-03-28 | 2019-05-29 | FUJIFILM Manufacturing Europe B.V. | Wirkstofffreisetzungssystem umfassend RGD-angereicherte gelatineähnliche Proteine mit verstärkter Zellbindung |
US7352036B2 (en) | 2004-08-03 | 2008-04-01 | Fairchild Semiconductor Corporation | Semiconductor power device having a top-side drain using a sinker trench |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
US8673640B2 (en) * | 2005-09-20 | 2014-03-18 | National Institute For Materials Science | Porous scaffold, method of producing the same and method of using the porous scaffold |
US20070142762A1 (en) * | 2005-12-16 | 2007-06-21 | Eastman Kodak Company | Wound dressing |
CA2810522A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Polymorphs |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
US7319256B1 (en) | 2006-06-19 | 2008-01-15 | Fairchild Semiconductor Corporation | Shielded gate trench FET with the shield and gate electrodes being connected together |
US8685421B2 (en) * | 2006-07-07 | 2014-04-01 | Surmodics, Inc. | Beaded wound spacer device |
EP2082030A2 (de) * | 2006-10-20 | 2009-07-29 | Keracure, Inc. | Vorrichtungen mit auf biegsamen trägern kultivierten zellen |
KR100866577B1 (ko) * | 2007-09-28 | 2008-11-03 | 삼성전기주식회사 | 인쇄회로기판의 층간 도통방법 |
US20090202609A1 (en) * | 2008-01-06 | 2009-08-13 | Keough Steven J | Medical device with coating composition |
EP2077118A1 (de) * | 2008-01-07 | 2009-07-08 | Gwo Rei Biomedical Technology Corp. | Gerinnungsfähiges Konzentrat von Plättchenwachstumsfaktoren und Herstellungsverfahren dafür |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
JP2012512848A (ja) | 2008-12-23 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 有機化合物の塩の形態 |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
BR112012012641A2 (pt) | 2009-11-27 | 2020-08-11 | Boehringer Ingelheim International Gmbh | TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA |
WO2011084925A2 (en) | 2010-01-05 | 2011-07-14 | Cell Constructs, Inc. | Biomaterials made from human hair |
CA2797310C (en) | 2010-05-05 | 2020-03-31 | Boehringer Ingelheim International Gmbh | Glp-1 receptor agonist and dpp-4 inhibitor combination therapy |
AU2011268940B2 (en) | 2010-06-24 | 2015-05-21 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
US8962636B2 (en) | 2011-07-15 | 2015-02-24 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
KR20140097256A (ko) | 2011-11-02 | 2014-08-06 | 할사이온, 인크. | 상처 치료를 위한 방법들 및 조성물들 |
KR101335176B1 (ko) * | 2011-12-12 | 2013-11-29 | 테고사이언스 (주) | 상처 치유용 드레싱재제 |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
EP2849755A1 (de) | 2012-05-14 | 2015-03-25 | Boehringer Ingelheim International GmbH | Xanthinderivat als dpp-4-hemmer zur verwendung bei der behandlung von durch podozyten vermittelten erkrankungen und/oder des nephrotischen syndroms |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
EP2854824A1 (de) * | 2012-05-25 | 2015-04-08 | Boehringer Ingelheim International GmbH | Verwendung von keratinozyten als einer biologisch aktive substanz in der behandlung von wunden wie diabätische wunden, gegebenenfalls in kombination mit einem dpp-4-hemmer |
EP2908870B1 (de) | 2012-10-16 | 2018-05-23 | SurModics, Inc. | Wundverpackungsvorrichtung und -verfahren |
WO2015128453A1 (en) | 2014-02-28 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
US10201457B2 (en) | 2014-08-01 | 2019-02-12 | Surmodics, Inc. | Wound packing device with nanotextured surface |
EP3132809A1 (de) * | 2015-08-21 | 2017-02-22 | Bioskinco GmbH | Zusammensetzung und produkte mit alterungszellen zur geweberegeneration |
EP4233840A3 (de) | 2016-06-10 | 2023-10-18 | Boehringer Ingelheim International GmbH | Kombinationen aus linagliptin und metformin |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4576715A (en) * | 1981-02-13 | 1986-03-18 | Dresser Industries, Inc | Membrane pack and method of making |
US4997443A (en) * | 1985-08-26 | 1991-03-05 | Hana Biologics, Inc. | Transplantable artificial tissue and process |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US5015584A (en) * | 1987-10-14 | 1991-05-14 | Board Of Regents, The University Of Texas System | Epidermal graft system |
US5418154A (en) * | 1987-11-17 | 1995-05-23 | Brown University Research Foundation | Method of preparing elongated seamless capsules containing biological material |
IL94611A (en) * | 1989-06-05 | 1994-12-29 | Organogenesis Inc | Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use |
US5763266A (en) * | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
WO1991001720A1 (en) * | 1989-08-07 | 1991-02-21 | Herman Wade Schlameus | Composition and method of promoting hard tissue healing |
US5529914A (en) * | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
BG51904A1 (en) * | 1991-04-16 | 1993-11-15 | Serdev | Method foe epithelium cell covering of open wounds |
RU2010028C1 (ru) * | 1991-06-28 | 1994-03-30 | Васильев Андрей Валентинович | Способ восстановления кожного покрова у тяжелообожженных |
US5545423A (en) * | 1991-11-25 | 1996-08-13 | Vivorx, Inc. | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5269917A (en) * | 1992-02-28 | 1993-12-14 | Millipore Corporation | Filtration apparatus having stress relief groove |
GB9210574D0 (en) * | 1992-05-18 | 1992-07-01 | Ca Nat Research Council | Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications |
US5512474A (en) * | 1992-05-29 | 1996-04-30 | Bsi Corporation | Cell culture support containing a cell adhesion factor and a positively-charged molecule |
EP0648264A4 (de) * | 1992-06-03 | 1997-10-01 | Univ Case Western Reserve | Permanenter verband zur verabreichung von biologischen produkten. |
IT231279Y1 (it) | 1993-10-13 | 1999-08-02 | Abate Luigi | Elemento tubolare per la formazione di sacchetti per il confezionamento di prodotti sottovuoto |
US5563068A (en) * | 1994-04-21 | 1996-10-08 | Genetic Therapy, Inc. | Bioreactor |
IL115728A0 (en) * | 1994-10-25 | 1996-01-19 | Boehringer Mannheim Gmbh | Biomaterial containing epithelial cells and use thereof as a transplant |
US5741685A (en) * | 1995-06-07 | 1998-04-21 | Children's Medical Center Corporation | Parenchymal cells packaged in immunoprotective tissue for implantation |
US5693332C1 (en) * | 1995-08-11 | 2001-01-09 | Univ California | Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure |
US5972332A (en) * | 1997-04-16 | 1999-10-26 | The Regents Of The University Of Michigan | Wound treatment with keratinocytes on a solid support enclosed in a porous material |
-
1997
- 1997-04-16 US US08/840,804 patent/US5972332A/en not_active Expired - Lifetime
-
1998
- 1998-04-15 AU AU69711/98A patent/AU6971198A/en not_active Abandoned
- 1998-04-15 DE DE1998632054 patent/DE69832054T2/de not_active Expired - Lifetime
- 1998-04-15 ES ES05022145T patent/ES2292034T3/es not_active Expired - Lifetime
- 1998-04-15 WO PCT/US1998/007480 patent/WO1998046082A1/en active IP Right Grant
- 1998-04-15 EP EP98915561A patent/EP0975226B1/de not_active Expired - Lifetime
- 1998-04-15 DE DE1998638356 patent/DE69838356T2/de not_active Expired - Lifetime
- 1998-04-15 AT AT98915561T patent/ATE307621T1/de not_active IP Right Cessation
- 1998-04-15 ES ES98915561T patent/ES2252830T3/es not_active Expired - Lifetime
- 1998-04-15 EP EP05022145A patent/EP1640024B1/de not_active Expired - Lifetime
-
1999
- 1999-05-27 US US09/323,188 patent/US20010014674A1/en not_active Abandoned
- 1999-06-22 US US09/338,413 patent/US6197330B1/en not_active Expired - Lifetime
-
2000
- 2000-12-22 US US09/747,742 patent/US6299898B2/en not_active Expired - Lifetime
-
2001
- 2001-07-31 US US09/919,516 patent/US6440452B2/en not_active Expired - Lifetime
-
2002
- 2002-06-25 US US10/178,342 patent/US6890552B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030124173A1 (en) | 2003-07-03 |
DE69832054D1 (de) | 2005-12-01 |
EP0975226A1 (de) | 2000-02-02 |
EP1640024B1 (de) | 2007-08-29 |
ES2292034T3 (es) | 2008-03-01 |
EP0975226A4 (de) | 2000-11-08 |
AU6971198A (en) | 1998-11-11 |
DE69832054T2 (de) | 2006-07-20 |
EP1640024A2 (de) | 2006-03-29 |
ES2252830T3 (es) | 2006-05-16 |
EP0975226B1 (de) | 2005-10-26 |
EP1640024A3 (de) | 2006-04-05 |
DE69838356T2 (de) | 2008-05-21 |
US6197330B1 (en) | 2001-03-06 |
US20010001039A1 (en) | 2001-05-10 |
WO1998046082A1 (en) | 1998-10-22 |
US20020015725A1 (en) | 2002-02-07 |
US6299898B2 (en) | 2001-10-09 |
US5972332A (en) | 1999-10-26 |
US20010014674A1 (en) | 2001-08-16 |
US6890552B2 (en) | 2005-05-10 |
DE69838356D1 (de) | 2007-10-11 |
US6440452B2 (en) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE307621T1 (de) | Mit zellen beschichtete träger | |
ATE380559T1 (de) | Konjugate enthaltend ein antitumorales mittel und deren verwendung | |
DE69427716D1 (de) | Klebeverband zur Blutstillung | |
PT1222941E (pt) | Dispositivo medico flexivel | |
MX170492B (es) | Vendaje adhesivo absorbente | |
DE69505176D1 (de) | Poly(meth)acrylate-Hydrogelklebmittel | |
HU0001175D0 (en) | Multilayered analytical device | |
NO20025608L (no) | Kombinert SIS- og vakuumbandasje og fremgangsmåte | |
NO960724D0 (no) | Middel for transdermal applisering inneholdende gestodenestere | |
BR9305783A (pt) | Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água | |
LU79534A1 (de) | Mehrkanalsystem zur handhabung von immobilisierten biologisch-aktiven substanzen | |
DE69411030D1 (de) | Osmotische und kapillare absorbierstruktur unterschiedlicher dichte und verfahren zu ihrer herstellung | |
NO984627L (no) | Implanterbare, agarose-kollagenperler inneholdende celler som produserer et diffuserbart biologisk produkt og anvendelser derav | |
IT230274Y1 (it) | Pannolone assorbente sagomato per incontinenza | |
IT1309588B1 (it) | Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi. | |
DE69800433D1 (de) | PSA Verfahren unter Verwendung eines Adsorptionmittels mit heterogener Kapazität und/oder Selektivität | |
FR2711056B1 (fr) | Pansement adhésif absorbant. | |
ES2132027A1 (es) | Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante. | |
DE69807402D1 (de) | Killer-T-Zell Aktivator und dessen Verwendung | |
ATE243252T1 (de) | Pharmazeutische zusammensetzung enthaltend durch pim aktivierten nkt zellen, und ihr verwendung in der therapie | |
FI943441A (fi) | Tris-karbamiinihapon estereitä: kolesterolin absorption ehkäisyaineita | |
DK407189D0 (da) | Materiale, som indeholder formamidgruppeholdige (meth)acrylsyreestere, dets fremstilling og anvendelse | |
AU2003288363A1 (en) | Support for receiving molecules having an activity and method for ensuring the presence of said molecules on said support | |
DE59712215D1 (de) | Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination | |
FR2634357B1 (fr) | Pantoufle souple, lavable et sterilisable |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |